9-136364515-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS1
The NM_052813.5(CARD9):c.1479G>A(p.Arg493Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000065 in 1,539,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00034 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000035 ( 0 hom. )
Consequence
CARD9
NM_052813.5 synonymous
NM_052813.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0530
Publications
0 publications found
Genes affected
CARD9 (HGNC:16391): (caspase recruitment domain family member 9) The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008]
CARD9 Gene-Disease associations (from GenCC):
- deep dermatophytosisInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- predisposition to invasive fungal disease due to CARD9 deficiencyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 9-136364515-C-T is Benign according to our data. Variant chr9-136364515-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 535821.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.053 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000335 (51/152214) while in subpopulation AFR AF = 0.00113 (47/41464). AF 95% confidence interval is 0.000875. There are 0 homozygotes in GnomAd4. There are 23 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CARD9 | NM_052813.5 | c.1479G>A | p.Arg493Arg | synonymous_variant | Exon 12 of 13 | ENST00000371732.10 | NP_434700.2 | |
| CARD9 | NM_052814.4 | c.1441+38G>A | intron_variant | Intron 12 of 12 | NP_434701.1 | |||
| LOC124902309 | XR_007061863.1 | n.84+1063C>T | intron_variant | Intron 1 of 1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CARD9 | ENST00000371732.10 | c.1479G>A | p.Arg493Arg | synonymous_variant | Exon 12 of 13 | 1 | NM_052813.5 | ENSP00000360797.5 | ||
| ENSG00000289701 | ENST00000696169.1 | n.*1107G>A | non_coding_transcript_exon_variant | Exon 11 of 13 | ENSP00000512460.1 | |||||
| ENSG00000289701 | ENST00000696169.1 | n.*1107G>A | 3_prime_UTR_variant | Exon 11 of 13 | ENSP00000512460.1 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152214Hom.: 0 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
51
AN:
152214
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000765 AC: 11AN: 143708 AF XY: 0.0000517 show subpopulations
GnomAD2 exomes
AF:
AC:
11
AN:
143708
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000353 AC: 49AN: 1386916Hom.: 0 Cov.: 32 AF XY: 0.0000263 AC XY: 18AN XY: 684450 show subpopulations
GnomAD4 exome
AF:
AC:
49
AN:
1386916
Hom.:
Cov.:
32
AF XY:
AC XY:
18
AN XY:
684450
show subpopulations
African (AFR)
AF:
AC:
42
AN:
31562
American (AMR)
AF:
AC:
3
AN:
35692
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25170
East Asian (EAS)
AF:
AC:
0
AN:
35760
South Asian (SAS)
AF:
AC:
0
AN:
79186
European-Finnish (FIN)
AF:
AC:
0
AN:
37850
Middle Eastern (MID)
AF:
AC:
0
AN:
5060
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1078814
Other (OTH)
AF:
AC:
4
AN:
57822
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000335 AC: 51AN: 152214Hom.: 0 Cov.: 34 AF XY: 0.000309 AC XY: 23AN XY: 74358 show subpopulations
GnomAD4 genome
AF:
AC:
51
AN:
152214
Hom.:
Cov.:
34
AF XY:
AC XY:
23
AN XY:
74358
show subpopulations
African (AFR)
AF:
AC:
47
AN:
41464
American (AMR)
AF:
AC:
4
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68024
Other (OTH)
AF:
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Predisposition to invasive fungal disease due to CARD9 deficiency Benign:1
May 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.